Presentation TCT 2014 Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy Presenter: Dietmar Trenk September 16, 2014 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2014 Up Next Presentation TCT 2014 Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___ Presenter: James Min September 16, 2014 More slides + Presentation TCT 2014 N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement Presenter: Ronald Binder September 16, 2014 Presentation TCT 2014 Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing? Presenter: Michael D. Ezekowitz September 15, 2014 We Recommend
Presentation TCT 2014 Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___ Presenter: James Min September 16, 2014
Presentation TCT 2014 N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement Presenter: Ronald Binder September 16, 2014
Presentation TCT 2014 Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing? Presenter: Michael D. Ezekowitz September 15, 2014